JPWO2022112490A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022112490A5
JPWO2022112490A5 JP2023532331A JP2023532331A JPWO2022112490A5 JP WO2022112490 A5 JPWO2022112490 A5 JP WO2022112490A5 JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023532331 A JP2023532331 A JP 2023532331A JP WO2022112490 A5 JPWO2022112490 A5 JP WO2022112490A5
Authority
JP
Japan
Prior art keywords
quinazolin
fluorophenyl
alkyl
methyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023532331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023550840A5 (https=
JP2023550840A (ja
JP7844468B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/083141 external-priority patent/WO2022112490A1/en
Publication of JP2023550840A publication Critical patent/JP2023550840A/ja
Publication of JP2023550840A5 publication Critical patent/JP2023550840A5/ja
Publication of JPWO2022112490A5 publication Critical patent/JPWO2022112490A5/ja
Application granted granted Critical
Publication of JP7844468B2 publication Critical patent/JP7844468B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023532331A 2020-11-27 2021-11-26 P2x3阻害剤としてのアミノキナゾリン誘導体 Active JP7844468B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20210189.5 2020-11-27
EP20210189 2020-11-27
PCT/EP2021/083141 WO2022112490A1 (en) 2020-11-27 2021-11-26 Amino quinazoline derivatives as p2x3 inhibitors

Publications (4)

Publication Number Publication Date
JP2023550840A JP2023550840A (ja) 2023-12-05
JP2023550840A5 JP2023550840A5 (https=) 2024-11-29
JPWO2022112490A5 true JPWO2022112490A5 (https=) 2024-11-29
JP7844468B2 JP7844468B2 (ja) 2026-04-13

Family

ID=73642588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023532331A Active JP7844468B2 (ja) 2020-11-27 2021-11-26 P2x3阻害剤としてのアミノキナゾリン誘導体

Country Status (10)

Country Link
US (1) US20240025880A1 (https=)
EP (1) EP4251620B1 (https=)
JP (1) JP7844468B2 (https=)
KR (1) KR20230113309A (https=)
CN (1) CN116601149A (https=)
AU (1) AU2021388923A1 (https=)
CA (1) CA3196333A1 (https=)
ES (1) ES3026309T3 (https=)
MX (1) MX2023005803A (https=)
WO (1) WO2022112490A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121368584A (zh) 2023-05-22 2026-01-20 奇斯药制品公司 用于制备p2x3抑制剂的方法及中间体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2592070B1 (en) 2006-06-29 2016-08-31 F. Hoffmann-La Roche AG Tetrazole-substituted arylamides
CA2682162C (en) 2007-04-02 2016-05-10 Renovis, Inc. Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
JP5498374B2 (ja) 2007-04-17 2014-05-21 エボテック・アーゲー 2−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用
MX2010009561A (es) 2008-02-29 2010-09-24 Renovis Inc Compuestos amida, composiciones y usos de los mismos.
CA2737038A1 (en) 2008-09-18 2010-03-25 Evotec Ag Amide compounds, compositions and uses thereof
WO2016084922A1 (ja) 2014-11-28 2016-06-02 塩野義製薬株式会社 1,2,4-トリアジン誘導体およびその医薬組成物
WO2016088838A1 (ja) 2014-12-04 2016-06-09 塩野義製薬株式会社 プリン誘導体およびその医薬組成物
HUE058009T2 (hu) 2014-12-09 2022-06-28 Bayer Ag 1,3-Tiazol-2-il szubsztituált benzamid-származékok
WO2017011729A1 (en) 2015-07-16 2017-01-19 Patara Pharma, LLC Combination therapies for the treatment of lung diseases
KR20180054843A (ko) 2015-09-29 2018-05-24 애퍼런트 파마슈티컬스 인크. 기침 치료에 사용하기 위한 디아미노피리미딘 p2x3 및 p2x2/3 수용체 조정제
BR112021022099A2 (pt) * 2019-05-31 2021-12-28 Chiesi Farm Spa Derivados de amino quinazolina como inibidores de p2x3

Similar Documents

Publication Publication Date Title
JP6907173B2 (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
AU769449B2 (en) Piperidines as CCR5 modulators
JP6422438B2 (ja) RORγT阻害剤としての4−ヘテロアリール置換安息香酸化合物およびその使用
KR100862879B1 (ko) Hiv 인테그라제의 n-치환된 하이드록시피리미디논 카복스아미드 억제제
CN105764514B (zh) 作为tam族激酶抑制剂的氨基吡啶衍生物
CN109952289B (zh) Trpv4拮抗剂
KR102616949B1 (ko) 고리형 구조를 갖는 화합물
JP6854386B2 (ja) リゾホスファチジン酸受容体1(lpar1)阻害剤化合物
EP3022202A1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
CN101511812A (zh) 作为细胞色素p450抑制剂的吡唑衍生物
CA2983668C (en) Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors
ES2533095T3 (es) Agonistas de receptores de esfingosina-1-fosfato
TW202102474A (zh) 吡咯化合物
JP2014513122A5 (https=)
RU2013152961A (ru) Изоксазолины в качестве терапевтических агентов
WO2019054430A1 (ja) 芳香族複素環を有するアミド化合物
ES2231439T3 (es) Derivados benzooxazol como inhibidores de tnf y de pde iv.
JPWO2022112490A5 (https=)
WO2005100341A1 (ja) 2-アミノピリミジン誘導体
CN104853757A (zh) 作为RORγT抑制剂的4-杂芳基取代的苯甲酸化合物及其用途
JP2024508817A (ja) B型肝炎ウイルス感染症の処置および予防のためのベンゾチアゾリルビシクロ[1.1.1]ペンタン誘導体
IL296632A (en) phd inhibitory compounds, compositions and use
TWI881587B (zh) 類木瓜蛋白酶(PLpro)抑制劑
WO2023220225A1 (en) Inhibitors of human respiratory syncytial virus and metapneumovirus
KR20240020201A (ko) 저산소증 유도 인자 1(hif-1) 억제제 또는 혈관내피성장인자(vegf)억제제 로서의 신규 화합물 및 이를 포함하는 약학적 조성물